Your browser doesn't support javascript.
loading
Practical Clinical Guidelines for Natalizumab Treatment in Patients With Relapsing Multiple Sclerosis.
O'Leary, Shirley; Brugger, Helen T; Wallentine, Dale; Sershon, Lisa; Goff, Erica; Saldana-King, Toni; Beavin, Jill; Avila, Robin L; Rutledge, Danette; Moore, Marie.
Afiliação
  • O'Leary S; Dallas VA Medical Center MS Center, Dallas, Texas (Ms O'Leary); Long Ridge Medical Center, Neurology, Greenwich Hospital, Stamford, Connecticut (Ms Brugger); Rocky Mountain MS Clinic, Salt Lake City, Utah (Mr Wallentine); The Regional MS Center & The Center for Neurological Disorders, Milwaukee,
  • Brugger HT; Shirley O'Leary, MS, APN-C, MSCN, has practiced as a provider, subinvestigator/researcher, and neurology infusion manager for 7 years at the MS Center of Excellence at the Dallas VA Medical Center. She has 27 years of experience in the area of multiple sclerosis (MS) and has authored articles, given
  • Wallentine D; Helen T. Brugger, DNP, MSN, RN, Coordinator of Long Ridge Infusion Center at Long Ridge Medical Center, Greenwich Hospital, has worked on 2 intravenous teams and currently treats a population of neurological patients at an outpatient infusion center. She is a member of the Eastern Nursing Research S
  • Sershon L; Dale Wallentine, BSN, RN, MSCN, is an infusion nurse and the infusion department operation manager at the Rocky Mountain Multiple Sclerosis Clinic in Salt Lake City. He has more than 13 years of multiple sclerosis infusion experience and is certified in multiple sclerosis nursing.
  • Goff E; Lisa Sershon, PA-C, MMS, MSCS,* practiced for 11 years as a physician's assistant specializing in neuroimmunology, at the Center for Neurological Disorders at Ascension St. Francis in Milwaukee, Wisconsin. She participated in the management and protocol development for infusion therapies as a multip
  • Saldana-King T; Erica Goff, PharmD, BCPS, MSCS, is a specialty pharmacist covering the multiple sclerosis population at the outpatient neurology division at University of Alabama at Birmingham Health System. Her professional responsibilities include clinical guidance, oversight, and patient education for pharmacoth
  • Beavin J; Toni Saldana-King, RN, BSN, MSCN, was a senior medical science liaison at Biogen at the time of submission. Prior to Biogen, she was a practicing nurse at the Maxine Mesinger MS Comprehensive Care Center at Baylor College of Medicine in Houston, Texas, the first Comprehensive Care Center to be recog
  • Avila RL; Jill Beavin, BSN, RN, MSCN, is a principle medical science liaison at Biogen. Prior to Biogen, she worked as an MS nurse and clinical director in a private neurology practice, where she developed and maintained a 22-chair infusion suite and MS Center.
  • Rutledge D; Robin L. Avila, PhD, is a medical director at Biogen and has been involved in MS clinical research for the last 6 years. Prior to Biogen, she conducted preclinical MS research in the areas of myelin biology, myelin repair, and the development of novel models of MS.
  • Moore M; Danette Rutledge, BSP, PhD, is an associate medical director at Biogen, where she has been involved in MS clinical research for the last 3 years. Prior to joining industry, she conducted basic science research in multiple sclerosis for over 10 years.
J Infus Nurs ; 46(6): 347-359, 2023.
Article em En | MEDLINE | ID: mdl-37920108

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucoencefalopatia Multifocal Progressiva / Esclerose Múltipla Limite: Adult / Humans Idioma: En Revista: J Infus Nurs Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucoencefalopatia Multifocal Progressiva / Esclerose Múltipla Limite: Adult / Humans Idioma: En Revista: J Infus Nurs Ano de publicação: 2023 Tipo de documento: Article